C210S (p.Cys210Ser) variant of ITGB3 (Integrin beta-3)
C210S (p.Cys210Ser) in ITGB3 (Integrin beta-3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Glanzmann thrombasthenia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.86 / 1. The record also includes structural context.
C210S (p.Cys210Ser) variant details
- p.Cys210Ser
- rs2065102210
- ClinGen CA400023389
- ClinVar RCV001225284
- Ensembl rs2065102210
- Pathogenic
- Glanzmann thrombasthenia
- Missense
- Variant Prioritization Score for Impact Estimate 0.861
- AlphaMissense 1.00
- MetaLR 0.90
- MetaSVM 1.02
- PolyPhen-2 1.00
- SIFT 0.00
- EVE 0.61
- ClinVar: Pathogenic (Glanzmann thrombasthenia)
- EBI: Pathogenic
- UniProt: Pathogenic
- Structural context available